151 related articles for article (PubMed ID: 30050113)
1. PP2A negatively regulates the hypertrophic response by dephosphorylating HDAC2 S394 in the heart.
Yoon S; Kook T; Min HK; Kwon DH; Cho YK; Kim M; Shin S; Joung H; Jeong SH; Lee S; Kang G; Park Y; Kim YS; Ahn Y; McMullen JR; Gergs U; Neumann J; Kim KK; Kim J; Nam KI; Kim YK; Kook H; Eom GH
Exp Mol Med; 2018 Jul; 50(7):1-14. PubMed ID: 30050113
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of heat shock protein 70 blocks the development of cardiac hypertrophy by modulating the phosphorylation of histone deacetylase 2.
Yoon S; Kim M; Min HK; Lee YU; Kwon DH; Lee M; Lee S; Kook T; Joung H; Nam KI; Ahn Y; Kim YK; Kim J; Park WJ; McMullen JR; Eom GH; Kook H
Cardiovasc Res; 2019 Nov; 115(13):1850-1860. PubMed ID: 30596969
[TBL] [Abstract][Full Text] [Related]
3. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
[TBL] [Abstract][Full Text] [Related]
4. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
5. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression.
Morales CR; Li DL; Pedrozo Z; May HI; Jiang N; Kyrychenko V; Cho GW; Kim SY; Wang ZV; Rotter D; Rothermel BA; Schneider JW; Lavandero S; Gillette TG; Hill JA
Sci Signal; 2016 Apr; 9(422):ra34. PubMed ID: 27048565
[TBL] [Abstract][Full Text] [Related]
7. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
8. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling.
Ying H; Xu MC; Tan JH; Shen JH; Wang H; Zhang DF
Int J Mol Sci; 2014 Nov; 15(11):20240-53. PubMed ID: 25380525
[TBL] [Abstract][Full Text] [Related]
9. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.
Trivedi CM; Luo Y; Yin Z; Zhang M; Zhu W; Wang T; Floss T; Goettlicher M; Noppinger PR; Wurst W; Ferrari VA; Abrams CS; Gruber PJ; Epstein JA
Nat Med; 2007 Mar; 13(3):324-31. PubMed ID: 17322895
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.
Lu Y; Yang S
Tohoku J Exp Med; 2009 Sep; 219(1):17-23. PubMed ID: 19713680
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2.
Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J
Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094
[TBL] [Abstract][Full Text] [Related]
12. Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy.
Eom GH; Kook H
BMB Rep; 2015 Mar; 48(3):131-8. PubMed ID: 25388210
[TBL] [Abstract][Full Text] [Related]
13. Palmatine attenuates isoproterenol-induced pathological hypertrophy via selectively inhibiting HDAC2 in rats.
Yuan Y; Peng W; Liu Y; Xu Z
Int J Immunopathol Pharmacol; 2017 Dec; 30(4):406-412. PubMed ID: 29164959
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
Raghunathan S; Goyal RK; Patel BM
Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
[TBL] [Abstract][Full Text] [Related]
15. Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats.
Patel BM
Cardiovasc Toxicol; 2018 Feb; 18(1):1-8. PubMed ID: 28389765
[TBL] [Abstract][Full Text] [Related]
16. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
17. CKIP-1 inhibits cardiac hypertrophy by regulating class II histone deacetylase phosphorylation through recruiting PP2A.
Ling S; Sun Q; Li Y; Zhang L; Zhang P; Wang X; Tian C; Li Q; Song J; Liu H; Kan G; Cao H; Huang Z; Nie J; Bai Y; Chen S; Li Y; He F; Zhang L; Li Y
Circulation; 2012 Dec; 126(25):3028-40. PubMed ID: 23151343
[TBL] [Abstract][Full Text] [Related]
18. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
19. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
20. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
